Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +17819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| p-Ethynylphenylalanine | C11H11NO2 | 278605-15-5 | Details |
| 2',3'-cGAMP；2'-3'-cyclic GMP-AMP | C20H24N10O13P2 | 1441190-66-4 | Details |
| A2B receptor antagonist 1 | C21H24N6O2 | 531506-36-2 | Details |
| Anti-inflammatory agent 1 | C17H16O3S | 1096621-42-9 | Details |
| Thrombin inhibitor 1 | C22H20Cl2F2N4O3 | 855998-46-8 | Details |
| 3-Deazaadenosine hydrochloride | C11H15ClN4O4 | 86583-19-9 | Details |
| (1S,2S,3R)-DT-061 | C25H23F3N2O5S | 1809427-20-0 | Details |
| (2S,3S)-E1R | C13H16N2O2 | 1424832-57-4 | Details |
| 2',5'-Dideoxyadenosine | C10H13N5O2 | 6698-26-6 | Details |
| 2'-Deoxypseudoisocytidine | C9H13N3O4 | 65358-18-1 | Details |
| 2-Methyl-5-HT hydrochloride；2-Methyl-5-hydroxytryptamine hydrochloride | C11H15ClN2O | 845861-49-6 | Details |
| Cephalexin | C16H17N3O4S | 15686-71-2 | Details |
| (1S,2S)-Bortezomib | C19H25BN4O4 | 1132709-14-8 | Details |
| (3S,5R)-Pitavastatin calcium | C25H26CaFNO4 | 254452-88-5 | Details |
| 4-Desmethyl Istradefylline | C19H22N4O4 | 160434-48-0 | Details |
| AMPK activator 1 | C32H33F3N4O3 | 1152423-98-7 | Details |
| PSN-GK1 | C20H23FN2O4S2 | 745051-61-0 | Details |
| 2'-Azido-2'-deoxyuridine；N3dUrd | C9H11N5O5 | 26929-65-7 | Details |
| 2-Keto-D-Glucose；D-Glucosone | C6H10O6 | 1854-25-7 | Details |
| E1R | C13H16N2O2 | 1301211-78-8 | Details |
| Desethyl KBT-3022 | C23H20N2O4S | 101001-72-3 | Details |
| Nanofin | C7H15N | 504-03-0 | Details |
| LDL-IN-3 | C24H36O3Si | 180908-67-2 | Details |
| QF0301B | C23H28N2O2 | 149247-12-1 | Details |
| Anti-neurodegeneration agent 1 | C14H20ClN3O3 | 289893-23-8 | Details |
| 20(S)-Hydroxycholesterol | C27H46O2 | 516-72-3 | Details |
| 3,4-Dihydroxybenzylamine hydrobromide | C7H10BrNO2 | 16290-26-9 | Details |
| 2-Methylcitric acid trisodium；Methylcitric acid trisodium | C7H7O7*3Na | 117041-96-0 | Details |
| DT-061 | C25H23F3N2O5S | 1809427-19-7 | Details |
| 3-Nitrocoumarin | C9H5NO4 | 28448-04-6 | Details |
| 3-CPs | C14H10O5 | 20073-24-9 | Details |
| 4-Hydroxyacetophenone oxime | C8H9NO2 | 34523-34-7 | Details |
| 2-Hydroxy Ibuprofen；(±)-2-Hydroxy Ibuprofen | C13H18O3 | 51146-55-5 | Details |
| 3-arylisoquinolinamine derivative | C18H19N3O | 1029008-71-6 | Details |
| 24R-Calcipotriol；PRI 2202 | C27H40O3 | 112827-99-3 | Details |
| 3'-Azido-3'-deoxy-5-methylcytidine | C10H14N6O4 | 1282040-14-5 | Details |
| Neuromuscular Disorder-Targeting Compound 1 | C15H25N3S | 374538-23-5 | Details |
| PGS-IN-1 | C19H26O3 | 102271-49-8 | Details |
| DPP-IV-IN-1 | C11H18FN3O2 | 625110-37-4 | Details |
| Antiulcer Agent 1 | C19H23N3O4 | 76001-09-7 | Details |
| Acebutolol hydrochloride | C18H29ClN2O4 | 34381-68-5 | Details |
| 3-Hydroxy-4-methoxyacetophenone | C9H10O3 | 6100-74-9 | Details |
| 2'-Ethyl Simvastatin | C23H34O5 | 79902-42-4 | Details |
| 3-O-Methyltolcapone；Ro 40-7591 | C15H13NO5 | 134612-80-9 | Details |
| 24-Norursodeoxycholic acid | C23H38O4 | 99697-24-2 | Details |
| 3-Oxo Atorvastatin | C33H33FN2O5 | 887196-30-7 | Details |
| (3S,5S)-Pitavastatin calcium | C25H26CaFNO4 | 254452-92-1 | Details |
| 2-Methylcitric acid；Methylcitric acid | C7H10O7 | 6061-96-7 | Details |
| 3-Hydroxy agomelatine D3 | C15H17NO3 | 1079774-23-4 | Details |
| MAO-IN-1 | C17H19ClO4 | 124991-40-8 | Details |
| 3α-Hydroxymogrol | C30H52O4 | 1343402-73-2 | Details |
| (-)-GSK598809；1S,5R-GSK598809 | C22H23F4N5OS | 863680-46-0 | Details |
| (2R,3S)-E1R | C13H16N2O2 | 1424832-60-9 | Details |
| Itraconazole | C35H38Cl2N8O4 | 84625-61-6 | Details |
| 2-Methyl-5-HT maleate；2-Methylserotonin maleate;2-Methyl-5-hydroxytryptamine maleate;2-Me-HT maleate | C15H18N2O5 | 78263-91-9 | Details |
| 4,7,10,13,16-Docosapentaenoic acid | C22H34O2 | 2313-14-6 | Details |
| 4-Diethylaminobenzaldehyde | C11H15NO | 120-21-8 | Details |
| (3S,5R)-Rosuvastatin | C22H28FN3O6S | 1242184-42-4 | Details |
| LH secretion antagonist 1 | C18H24ClNO2 | 88531-67-3 | Details |
| Calcium channel-modulator-1 | C26H24Cl2N2O7S | 136941-70-3 | Details |
| 2',5-Difluoro-2'-deoxycytidine | C9H11F2N3O4 | 581772-30-7 | Details |
| Estrone | C18H22O2 | 53-16-7 | Details |
| (2R,4R)-APDC | C6H10N2O4 | 169209-63-6 | Details |
| (3S,5R)-Fluvastatin D6 sodium；(3S,5R)-XU 62-320 D6 | C24H27FNNaO4 | 2249799-35-5 | Details |
| 3'-O-Acetylhamaudol | C17H18O6 | 30358-88-4 | Details |
| 3-Bromocytisine | C11H13BrN2O | 207390-14-5 | Details |
| VEGFR-2-IN-9；KDR-in-4 | C23H25N3O3 | 408502-06-7 | Details |
| (2S,3R)-Voruciclib | C22H19ClF3NO5 | 1253731-24-6 | Details |
| Propantheline bromide | C23H30BrNO3 | 50-34-0 | Details |
| CRTh2 antagonist 1 | C23H25N3O5S | 1379445-54-1 | Details |
| 3-O-Acetylbufotalin | C28H38O7 | 4029-69-0 | Details |
| 4'-Ethynyl-2'-deoxyadenosine | C12H13N5O3 | 306305-07-7 | Details |
| Amoxicillin trihydrate | C16H21N3O6S | 61336-70-7 | Details |
| 3,3'-Diiodo-L-thyronine；3,3'-T2 | C15H13I2NO4 | 4604-41-5 | Details |
| 2-O-β-D-Glucopyranosyl-L-ascorbic acid；AA-2βG | C12H18O11 | 562043-82-7 | Details |
| 24-Hydroxycholesterol | C27H46O2 | 30271-38-6 | Details |
| 2614W94 | C15H11F3O4S | 205187-35-5 | Details |
| Itch-Targeting Compound 1 | C25H36ClN3O3 | 793674-76-7 | Details |
| PF-592379 | C13H21N3O | 710655-15-5 | Details |
| 3-Carene | C10H16 | 13466-78-9 | Details |
| 2-Methyl-5-HT；2-Methyl-5-hydroxytryptamine | C11H14N2O | 78263-90-8 | Details |
| Verapamil hydrochloride | C27H39ClN2O4 | 152-11-4 | Details |
| Amikacin | C22H43N5O13 | 37517-28-5 | Details |
| 3-Bromo-7-nitroindazole | C7H4BrN3O2 | 74209-34-0 | Details |
| (3S,5R)-Fluvastatin sodium；(3S,5R)-XU 62-320 | C24H25FNNaO4 | 94061-81-1 | Details |
| 3-Hydroxy agomelatine | C15H17NO3 | 166526-99-4 | Details |
| 2-Iodomelatonin | C13H15IN2O2 | 93515-00-5 | Details |
| 4-Acetylsimvastatin | C27H40O6 | 145576-25-6 | Details |
| (2R,3R)-E1R | C13H16N2O2 | 1400888-63-2 | Details |
| 4-Hydroxyatomoxetine D3 | C17H21NO2 | 1217686-14-0 | Details |
| 3-Deazaadenosine | C11H14N4O4 | 6736-58-9 | Details |
| 4-Acetamidophenyl acetate | C10H11NO3 | 2623-33-8 | Details |
| 264W94 | C23H31NO4S | 178961-24-5 | Details |
| (3R,5S)-Atorvastatin sodium | C33H34FN2O5.Na | 131275-93-9 | Details |
| (3R,5R)-Rosuvastatin | C22H28FN3O6S | 1094100-06-7 | Details |
| 4-Desmethoxy Omeprazole | C16H17N3O2S | 110374-16-8 | Details |
| Substance P Receptor Antagonist 1 | C24H29F3N2O2 | 225526-17-0 | Details |
| 4-Bromo A23187；4-?Bromo A23187 | C29H36BrN3O6 | 76455-48-6 | Details |
| 4-Hydroxyatomoxetine | C17H21NO2 | 435293-66-6 | Details |
| (3R,4R)-A2-32-01 | C19H27NO2 | 1359752-95-6 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 | ||||